Evaluation of improving effects on fasting blood glucose of the test food.
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000031977
- Lead Sponsor
- CPCC Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Not provided
(1)Subjects using medical products. (2)Subjects who have a habit of ingesting medicine, health-promoting foods, foods for specified health uses, health foods that may affect this study. (3)Females who are pregnant or lactating, or who could become pregnant or lactating during test period. (4)Subjects who have a history of heart failure,liver failure, kidney failure, or digestive system disease. (5)Subjects who excessively take alcohol. (6)Subjects whose eating habits and rhythm of daily life are irregular (Shifts workers, late-night workers). (7)Subjects who have allergy for medicine and foods. (8) Subjects who are participating in other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate in other clinical tests. (9) Subjects who donated over 200mL blood and/or blood components within the last one month. (10) Males who donated over 400mL blood within the last three months. (11) Females who donated over 400mL blood within the last four months. (12) Males who will be collected over 1200 mL of blood when the planned sampling volume in this study is added to the volume collected within the last 12 months. (13) Females who will be collected over 800 mL of blood when the planned sampling volume in this study is added to the volume collected within the last 12 months. (14)Subjects who are not eligible for this study for some medical reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood glucose
- Secondary Outcome Measures
Name Time Method Immunoreactive insulin, Homeostasis model assessment of insulin resistance, Incremental blood glucose area under the curve.